Back to Journals » Breast Cancer: Targets and Therapy » Volume 5

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
9,279 Dovepress* 8,112 581+ 1,615 8,693
PubMed Central* 0 586 183 586
Totals 8,112 1,167 1,798 9,279
*Since 17 June 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 1 0 0 2 3

View citations on PubMed Central and Google Scholar